Galafold 123 MG

Ended Awarded

Contract number
36C24525N0177
Awardee
Awarding agency
Obligated
$21,089

Award facts

Contract value 100% obligated
$21,089.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of GALAFOLD 123 MG to the Department of Veterans Affairs (VA). The contract was awarded to Amicus Therapeutics US, LLC, a subsidiary of the biopharmaceutical company Amicus Therapeutics, Inc. The $21,089.47 firm fixed price delivery order has a completion date of November 19, 2024 and was awarded on November 14, 2024.

Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract (36F79724D0185) with the VA's Pharmaceuticals and Drugs schedule, which has a $13,024,630 ceiling value and a period of performance through August 31, 2029. Various VA Veterans Integrated Service Networks (VISNs) have awarded task orders against this FSS contract to procure Galafold, an enzyme replacement therapy for the treatment of Fabry disease. This contract does not have a set-aside designation, and Amicus Therapeutics US, LLC is the prime contractor with no identified subcontractors. The award supports the VA's mission to provide specialized healthcare services and medications to veterans across the country.

Quick answers

Who was awarded contract 36C24525N0177?

36C24525N0177 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 14, 2024.

How much is contract 36C24525N0177 worth?

The government has obligated $21,089 on 36C24525N0177.

Is contract 36C24525N0177 an order under another contract?

Yes. 36C24525N0177 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0177 competed?

The extent of competition for 36C24525N0177 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award